Header Logo

Connection

MURALI CHINTAGUMPALA to Antimetabolites, Antineoplastic

Back to Details
This is a "connection" page, showing publications MURALI CHINTAGUMPALA has written about Antimetabolites, Antineoplastic.
MURALI CHINTAGUMPALA
Connection Strength
0.096
Antimetabolites, Antineoplastic
  1. Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. Neuro Oncol. 2013 Jun; 15(6):759-66.
    View in: PubMed
    Score: 0.096
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.